Search alternatives:
system decrease » step decrease (Expand Search)
large decrease » larger decrease (Expand Search), marked decrease (Expand Search), large increases (Expand Search)
we decrease » a decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
_ system » _ systems (Expand Search), _ systemic (Expand Search)
a large » _ large (Expand Search)
Showing 1 - 20 results of 21,134 for search '(((( 17 ((we decrease) OR (_ decrease)) ) OR ( _ system decrease ))) OR ( a large decrease ))', query time: 0.54s Refine Results
  1. 1
    Decrease in loss during the training process.

    Decrease in loss during the training process. by Muhammad Idrees (92773)

    Published 2025
    Save to List
    Saved in:
  2. 2
    The linearly decreasing convergence factor a.

    The linearly decreasing convergence factor a. by Junhao Wei (6816803)

    Published 2025
    Save to List
    Saved in:
  3. 3
    Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts.

    Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts. by Gillian P. McHugo (8965919)

    Published 2025
    Save to List
    Saved in:
  4. 4
    Overview of the six original ACTIV-3/TICO trials.

    Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 5
    Baseline patient characteristics.

    Baseline patient characteristics. by Oscar F. C. van den Bosch (22184246)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    Mitigation (decreasing) scenario.

    Mitigation (decreasing) scenario. by Fabio Correddu (12501799)

    Published 2025
    Save to List
    Saved in:
  7. 7
    Bacterial abundance in L2 larvae collected from larval flasks inoculated with decreasing quantities of glycerol stock (bacteria source).

    Bacterial abundance in L2 larvae collected from larval flasks inoculated with decreasing quantities of glycerol stock (bacteria source). by Margaret V. Becker (21387776)

    Published 2025
    Save to List
    Saved in:
  8. 8
    Masking distance decreases pupillary responses.

    Masking distance decreases pupillary responses. by Inmaculada Márquez (19681346)

    Published 2024
    Save to List
    Saved in:
  9. 9
    Thermoneutrality decreased sepsis survival.

    Thermoneutrality decreased sepsis survival. by Goldia Chan (21453340)

    Published 2025
    Save to List
    Saved in:
  10. 10
    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…Background<p>Umbilical cord blood (UCB)-derived CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>low</sup> regulatory T cells (Tregs) can decrease albuminuria and anti-dsDNA IgG in systemic lupus erythematosus (SLE). …”
    Save to List
    Saved in:
  11. 11
    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…Background<p>Umbilical cord blood (UCB)-derived CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>low</sup> regulatory T cells (Tregs) can decrease albuminuria and anti-dsDNA IgG in systemic lupus erythematosus (SLE). …”
    Save to List
    Saved in:
  12. 12
    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…Background<p>Umbilical cord blood (UCB)-derived CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>low</sup> regulatory T cells (Tregs) can decrease albuminuria and anti-dsDNA IgG in systemic lupus erythematosus (SLE). …”
    Save to List
    Saved in:
  13. 13
    The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability.

    The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. by Zahra Hosseininia (22265113)

    Published 2025
    Save to List
    Saved in:
  14. 14
    An increase in MOI decreases neuronal dendrite numbers.

    An increase in MOI decreases neuronal dendrite numbers. by Emily Z. Tabaie (16630841)

    Published 2025
    Save to List
    Saved in:
  15. 15
    Fig 17 -

    Fig 17 - by Jianbo Jia (717814)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 16
    ECoG timescales decrease during spatial attention.

    ECoG timescales decrease during spatial attention. by Isabel Raposo (21615517)

    Published 2025
    Save to List
    Saved in:
  17. 17
    Effective contact rate over time for the different modelling scenarios considered: fixed, continuously increasing, continuously decreasing and with a step-decrease.

    Effective contact rate over time for the different modelling scenarios considered: fixed, continuously increasing, continuously decreasing and with a step-decrease. by Joshua Looker (21390948)

    Published 2025
    Save to List
    Saved in:
  18. 18
    Study Flow Diagram.

    Study Flow Diagram. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Antibody and antigen responses to Ensovibep vs placebo day 1–90.

    Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Baseline patient characteristics across neutralizing monoclonal antibody trials.

    Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: